3-hydroxy-3-methylglutaryl coa reductase inhibitor retards chicken embryonic growth

Momoka Sato, Mitsuhiro Furuse

研究成果: ジャーナルへの寄稿学術誌査読

抄録

In order to clarify the mechanism by which liver cholesterol content is elevated during chicken (Gallus gallus domesticus) embryonic development, fertilized eggs were administrated pravastatin in ovo, a 3-hydroxy-3-methylglutaryl CoA reductase (HMG-CoA reductase) inhibitor, at embryonic day 14 (E14). Embryonic growth and hepatic lipid content were determined at embryonic day 18 (El 8). Embryonic growth was retarded by pravastatin in a dose-dependent manner. In addition, hepatic total cholesterol, triacylglycerol and phospholipid contents were decreased with increased pravastatin. These results suggest that higher hepatic cholesterol was associated with HMG-CoA reductase activity and embryonic growth was affected by cholesterol synthesis.

本文言語英語
ページ(範囲)7
ページ数1
ジャーナルJournal of Applied Animal Research
36
1
DOI
出版ステータス出版済み - 2009

!!!All Science Journal Classification (ASJC) codes

  • 動物科学および動物学
  • 獣医学(全般)

フィンガープリント

「3-hydroxy-3-methylglutaryl coa reductase inhibitor retards chicken embryonic growth」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル